Creative Biolabs Is About To Stop Accepting New Applications For Fall 2017 Creative Biolabs Scholarship Program

Since the release of the Fall 2017 Creative Biolabs Scholarship Program, Creative Biolabs has received hundreds of applications from students around the world.

These candidates are pursing either bachelor’s degree, master’s degree or doctor's degree in universities or colleges such as Stanford University, Oxford University, Columbia University, State University of New York, etc.

The Fall 2017 Creative Biolabs Scholarship Program was set to help students with their financial problems. As a leading custom service provider specialized in the field of antibody production and engineering, Creative Biolabs is always happy to support young and ambitious talents in related fields.

In an effort to further support their research and higher education in the medical and science related field, Creative Biolabs announced its first Fall Scholarship Program at January 25, 2017. Similar to last season, undergraduate, graduate and Ph.D. students majoring in a science related field such as Biology, Biochemistry, Chemistry, and Molecular Biology are encouraged to apply.

Students who are interested in applying for this scholarship have to apply by August 15, 2017. There is only two weeks left before they stop accepting new applications.

Even though, this scholarship has its requirements. Applicants must be enrolled as a freshman, undergraduate, graduate or Ph.D. student at an accredited college or university and major in a science related field. In addition, all eligible candidates must reach a cumulative average grade of a B or 3.0 GPA. It also requires a written essay of at least 600 words, which can be an introduction to a new or a potential technology, a hot research topic the applicant has researched or is researching on, or anything else as long as it is Biomedical Engineering or Immunotherapy related.

Learn more about the Fall 2017 Creative Biolabs Scholarship Program .

About Creative Biolabs

Creative Biolabs is a leading custom service provider with extensive experience in antibody discovery and antibody production. Through over ten years of efforts, it has developed multiple pipelines and extended its service to over 26 countries. Delivering high-quality products and service is its commitment to clients.

Back to news